Colorado 2026 Regular Session Status: Passed Senate Bipartisan · 9 R · 4 D cosponsors

SB 140 — Exempt Drugs from Prescription Drug Affordability Board Reviews

Last action — House Committee on Health & Human Services Postpone Indefinitely

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the Senate. Introduced March 16, 2026. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the House.

Prognosis

Likely to advance 74% · high confidence

Where this bill stands today.

Odds of enactment

Moderate

How often bills like it became law.

  • Passed Senate

    Current position in the legislative process.

  • 19 sponsors

    14 primary, 5 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (9 R · 4 D) — cross-party backing.

  • Cleared a recorded vote

    Passed 2 recorded votes so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, a prescription drug that is:Designated as a drug for a rare disease or condition by the food and drug administration (FDA) of the federal department of health and human services; orA licensed biological product that is derived from human whole blood or plasma as indicated on product labeling approved by the FDA.(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

Bill Text

What changed in the latest version

21 added · 15 removed

Plain-language change summary

The updated version of Bill SB 140 adds a clarification that certain drugs designated for rare diseases by the FDA will be exempt from affordability reviews in Colorado. This change is important because it ensures that patients who need these specialized medications will not face additional financial scrutiny that could limit their access to necessary treatments. Overall, this amendment aims to protect the availability of crucial drugs for individuals with rare health conditions.

→
Previous
Latest
Second Regular Session Seventy-fifth General Assembly STATE OF COLORADO ENGROSSED This Version Includes All Amendments Adopted on Second Reading in the House of Introduction LLS NO.
Second Regular Session Seventy-fifth General Assembly STATE OF COLORADO REENGROSSED This Version Includes All Amendments Adopted in the House of Introduction LLS NO.
26-0737.01 Richard Sweetman x4333 SENATE BILL 26-140 SENATE SPONSORSHIP Frizell and Marchman, Amabile, Bright, Carson, Jodeh, Kirkmeyer, Simpson HOUSE SPONSORSHIP Gilchrist and Johnson, Bradfield, Hartsook, Joseph, Taggart Senate Committees House Committees Health & Human Services A BILL FOR AN ACT C ONCERNING EXEMPTING CERTAIN DRUGS FROM THE SCOPE OF AFFORDABILITY REVIEWS CONDUCTED BY THE C OLORADO PRESCRIPTION DRUG AFFORDABILITY REVIEW BOARD .
26-0737.01 Richard Sweetman x4333 SENATE BILL 26-140 SENATE SPONSORSHIP Frizell and Marchman, Amabile, Bright, Carson, Jodeh, Kirkmeyer, Simpson, Baisley, Coleman, Liston, Pelton B., Pelton R.
HOUSE SPONSORSHIP Gilchrist and Johnson, Bradfield, Hartsook, Joseph, Taggart Senate Committees House Committees Health & Human Services A BILL FOR AN ACT C ONCERNING EXEMPTING CERTAIN DRUGS FROM THE SCOPE OF AFFORDABILITY REVIEWS CONDUCTED BY THE C OLORADO PRESCRIPTION DRUG AFFORDABILITY REVIEW BOARD .
This summary applies to this bill as introduced and does notreflectanyamendmentsthatmaybesubsequentlyadopted.Ifthisbill passes third reading in the house of introduction, a bill summary that applies to the reengrossed version of this bill will be available at http://leg.colorado.gov.) The bill states that the Colorado prescription drug affordability reviewboardhasnoauthoritytoperformanaffordabilityreviewof,orto establish an upper payment limit for, a prescription drug that is:
This summary applies to this bill as introduced and does e n notreflectanyamendmentsthatmaybesubsequentlyadopted.Ifthisbill m 2 passes third reading in the house of introduction, a bill summary that T n 2 N g 3 applies to the reengrossed version of this bill will be available at E d i http://leg.colorado.gov.) S e p R A The bill states that the Colorado prescription drug affordability reviewboardhasnoauthoritytoperformanaffordabilityreviewof,orto establish an upper payment limit for, a prescription drug that is:
d ! Designated as a drug for a rare disease or condition by the n m 6 food and drug administration (FDA) of the federal T n 0 A g 9 Shading denotes HOUSE amendment.
d d ! Designated as a drug for a rare disease or condition by the e 6 food and drug administration (FDA) of the federal E a 2 A U 2 N n l Shading denotes HOUSE amendment.
E d r Capital letters or bold & italic numbers indicate new material to be added to existing lawA Dashes through the words or numbers indicate deletions from existing law.
S d r Capital letters or bold & italic numbers indicate new material to be added to existing law.e A Dashes through the words or numbers indicate deletions from existing law.
⬇ Download PDF
View plain text versions (3)

Action History

  1. House Committee on Health & Human Services Postpone Indefinitely

  2. Introduced In House - Assigned to Health & Human Services

  3. Senate Third Reading Passed - No Amendments

  4. Senate Third Reading Laid Over to 04/13/2026 - No Amendments

  5. Senate Second Reading Passed - No Amendments

  6. Senate Second Reading Laid Over to 04/09/2026 - No Amendments

  7. Senate Committee on Health & Human Services Refer Unamended to Senate Committee of the Whole

  8. Introduced In Senate - Assigned to Health & Human Services

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

14 sponsors · 5 co-sponsors · 82 not signed on · 2 voted No

Sponsors (14)

Co-sponsors (5)

Not signed on (82)

82 members have not signed on to this bill.

Show all 82 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Lay over the bill until May 15th.

Passed 11 Yea · 0 Nay · 2 Other
Party YeaNayPresentNot Voting
Republican 4001
Democrat 7001
Total 11002
% of votes cast 85%0%0%15%
How each member voted (13)
Member Party Vote
Eliza Hamrick Democrat Yea
Gretchen Rydin Democrat Yea
Karen McCormick Democrat Yea
Katie Stewart Democrat Yea
Lindsay Gilchrist Democrat Yea
Lisa Feret Democrat Yea
Regina English Democrat Not Voting
Sheila Lieder Democrat Yea
Brandi Bradley Republican Yea
Carlos Barron Republican Yea
Dan Woog Republican Not Voting
Dusty Johnson Republican Yea
Mary Bradfield Republican Yea

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 140 do?
The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, a prescription drug that is:Designated as a drug for a rare disease or condition by the food and drug administration (FDA) of the federal department of health and human services; orA licensed biological product that is derived from human whole blood or plasma as indicated on product labeling approved by the FDA.(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)
Who sponsors SB 140?
SB 140 is sponsored by R. Taggart, J. Joseph, A. Hartsook, M. Bradfield, D. Johnson, L. Gilchrist, Lisa Frizell (Republican), Janice Marchman (Democrat), Scott Bright (Republican), John Carson (Republican), Iman Jodeh (Democrat), Barbara Kirkmeyer (Republican), Mark Baisley (Republican), Larry Liston (Republican), Rod Pelton (Republican), Judy Amabile (Democrat), Cleave Simpson (Republican), Byron Pelton (Republican), and James Coleman (Democrat).
What is the current status of SB 140?
This bill has passed the Senate. Introduced March 16, 2026. It now moves to the second chamber.
Where can I track SB 140?
Track SB 140 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 140

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 140

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →